Aosaikang

Zhitong · Oct 28, 2025 at 05:39 AM

ASK PHARM released its performance for the first three quarters, with a net profit attributable to the parent company of 223 million yuan, a year-on-year increase of 75.81%

Zhitong · Oct 20, 2025 at 02:51 AM

Aosaikang: Innovative drug ASKB589 will announce clinical research data at the 2025 ESMO Annual Meeting

Zhitong · Oct 16, 2025 at 07:15 PM

Aosaikang's subsidiary signs ASKG712 project licensing agreement

Zhitong · Sep 25, 2025 at 08:40 PM

The innovative drug sector adjusted at the beginning of the trading session, with Aosaikang hitting the limit down, followed by declines in Cosunter, Jimin Health, Huili Pharmaceutical-W, Saili Medical, Rongchang Bio, Wanbangde, and others

Zhitong · Aug 28, 2025 at 06:29 AM

Aosaikang: Net profit of 160 million yuan in the first half of 2025, a year-on-year increase of 111.64%

Zhitong · Jul 16, 2025 at 04:37 AM

Aosaikang: Abnormal fluctuations in stock trading